Fig. 2 | Hypertension Research

Fig. 2

From: Long-term phase 3 study of esaxerenone as mono or combination therapy with other antihypertensive drugs in patients with essential hypertension

Fig. 2

Mean change from baseline in sitting BP (SBP/DBP) for each treatment group: a all patients and b monotherapy and combination therapy (full analysis set). Data are shown as the mean (95% confidence interval); paired t-test. *P < 0.0001 vs baseline. BP blood pressure, CCB calcium channel blocker, DBP diastolic BP, RAS renin–angiotensin system, SBP systolic BP

Back to article page